Acetylenic beta-sulfonamido and phosphinic acid amide...

C - Chemistry – Metallurgy – 07 – C

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C07C 311/29 (2006.01) A61K 31/18 (2006.01) A61K 31/664 (2006.01) A61P 19/02 (2006.01) C07C 309/42 (2006.01) C07C 309/87 (2006.01) C07F 9/53 (2006.01)

Patent

CA 2356345

The invention discloses hydroxamide acids of formula (B) which are useful in treating disease conditions mediated by TNF-.alpha., such as rheumatoid arthritis, osteoarthritis, sepsis, AIDS, ulcerative colitis, multiple sclerosis, Crohn's disease and degenerative cartilage loss. In the above formula, the dotted line represents an optional double bond, and R5, R6, R7, R8, R11, R12, X, Y and Z have the meanings given in the specification.

La présente invention concerne des acides hydroxamides représentés par la formule générale (B) convenant au traitement de pathologies à médiation des TNF-.alpha., et notamment la polyarthrite rhumatoïde, l'arthrose, la septicémie, le SIDA, la colite ulcéreuse, la sclérose en plaques, la maladie de Crohn et la dégénérescence des cartilages. Dans cette formule, les lignes en pointillés représentent une liaison double facultative. En outre, R¿5?, R¿6?, R¿7?, R¿8?, R¿11?, R¿12?, X, Y et Z sont tels que spécifiés dans la description.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Acetylenic beta-sulfonamido and phosphinic acid amide... does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Acetylenic beta-sulfonamido and phosphinic acid amide..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Acetylenic beta-sulfonamido and phosphinic acid amide... will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1982164

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.